Search
Descriptor English: CD30 Ligand
Descriptor Spanish: Ligando CD30
Descriptor Portuguese: Ligante CD30
Descriptor French: Ligand de CD30
Entry term(s): Antigen, CD153
Antigens, CD153
CD153 Antigen
CD153 Antigens
TNF Superfamily, Member 8
Tumor Necrosis Factor Ligand Superfamily Member 8
Tree number(s): D12.644.276.374.750.092
D12.776.395.550.177
D12.776.467.374.750.092
D12.776.543.550.196
D23.529.374.750.092
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D053285
Scope note: A membrane-bound tumor necrosis family member found primarily on activated T-LYMPHOCYTES that binds specifically to CD30 ANTIGEN. It may play a role in INFLAMMATION and immune regulation.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DE drug effects
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Public MeSH Note: 2007; CD30 LIGAND was indexed under TUMOR NECROSIS FACTORS & ANTIGENS, CD 2006, & under MEMBRANE GLYCOPROTEINS 1993-2005
History Note: 2007(1993)
DeCS ID: 52291
Unique ID: D053285
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2007/01/01
Date of Entry: 2006/07/05
Revision Date: 2017/05/24
CD30 Ligand - Preferred
Concept UI M0218957
Scope note A membrane-bound tumor necrosis family member found primarily on activated T-LYMPHOCYTES that binds specifically to CD30 ANTIGEN. It may play a role in INFLAMMATION and immune regulation.
Preferred term CD30 Ligand
Entry term(s) Antigen, CD153
Antigens, CD153
CD153 Antigen
CD153 Antigens
TNF Superfamily, Member 8
Tumor Necrosis Factor Ligand Superfamily Member 8



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey